Disappearance of glibenclamide-induced hypoglycemia in Wistar-Kyoto rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 3, 2006, Pages 574-576

  Sakamoto, Kenji ^a   Yonoki, Yuzuru ^a   Fujioka, Takamitsu ^a   Matsumura, Mizuho ^a   Mitsuta, Yoko ^a   Sano, Misako ^a   Saito, Maki ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Blood glucose; Glibenclamide; Insulin; Spontaneously hypertensive rats (SHR) Izm; Wistar Kyoto rats (WKY) Izm

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; GLUCOSE; GLUCOSE OXIDASE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME INACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE URINE LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; RADIOIMMUNOASSAY; RAT; RAT STRAIN;

AGING; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; GLUCOSE OXIDASE; GLYBURIDE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR;

EID: 33645240592     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.574     Document Type: Article

References (18)

1. Modan M., Halkin H., Almong S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z., J. Clin. Invest., 75, 809-817 (1985).
2. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., GBerilaqua S., New Eng. J. Med., 7, 317-350 (1987).
3. Swislocki A. L. M., Hoffman B. B., Reaven G. M., Am. J. Hypertens., 2, 419-423 (1989).
4. Reaven G. M., Diabetes Care, 14, 195-202 (1991).
5. Natalucci S., Burattini R., Boemi M., Fumelli P., Int. Med., 7, 27-35 (1999).
6. Pinto Y. M., Paul M., Ganten D., Cardiovasc. Res., 39, 77-88 (1998).
7. Mondon M., Reaven G. M., Metabolism, 37, 303-305 (1988).
8. Gaboury C. L., Karanja N., Holcomb S. R., Torok J., McCarron D. A., Am. J. Hypertension, 4, 661-666 (1991).
9. Hulman S., Falkner B., Freyvogel N., Metabolism, 42, 14-18 (1993).
10. Rao R. H., Diabetes, 42, 1364-1371 (1993).
11. Tsutsu N., Takata Y., Nunoi K., Kikuchi M., Takashiti S., Sadoshima S., Fujishima M., Metabolism, 38, 63-66 (1989).
12. Frontoni S., Ohman L., Haywood J. R., De Fronzo R. A., Rossetti L., Am. J. Physiol., 262, E191-E196 (1992).
13. Buchanan T. A., Sipos G. F., Madrilejo N., Chaplin L., Campese V. M., Am. J. Physiol., 262, E14-E19 (1992).
14. Buchanan T. A., Youn J. H., Campese V. M., Sipos G. F., Diabetes, 41, 872-878 (1992).
15. Katayama S., Inaba M., Maruno Y., Morita T., Awata T., Oka Y., Hypertens. Res., 20, 279-286 (1997).
16. Matsumoto K., Sakai T., Yamada T., Agui T., Nara Y., Yamori Y., Natori T., Hypertension, 218, 329-331 (1991).
17. Ishinaga Y., Nabika T., Shimada T., Hiraoka J., Nara Y., Yamori Y., Clin. Exp. Pharmacol. Physiol., 24, 18-22 (1997).
18. Kato N., Nabika T., Liang Y. Q., Mashimo T., Inomata H., Watanabe T., Yanai K., Yamori Y., Yazaki Y., Sasazuki T., Hypertension, 42, 1191-1197 (2003).